AngioDynamics to Acquire Eximo Medical for $46 Million
Eximo Medical develops a laser-based catheter device used for the treatment of occlusive peripheral arterial disease (PAD)
13:0903.10.19
Nasdaq-listed medical device company AngioDynamics Inc. has signed an agreement to acquire Israel-based medical device startup Eximo Medical Ltd. for $46 million upfront with up to $20 million contingent on milestones, the latter announced Thursday.
Eximo Medical CEO Yoel Zabar. Photo: PR
Founded in 2012 and based in central Israeli town Rehovot, Eximo Medical develops a laser-based catheter device used for the treatment of occlusive peripheral arterial disease (PAD). The company conducted clinical trials in Poland and its device is already being used in patients in the U.S. Following the acquisition, Eximo will continue to operate out of Israel, the company said in its statement.
Eximo Medical CEO Yoel Zabar. Photo: PR
